298 related articles for article (PubMed ID: 36877677)
21. Studying the Long-term Impact of COVID-19 in Kids (SLICK). Healthcare use and costs in children and young people following community-acquired SARS-CoV-2 infection: protocol for an observational study using linked primary and secondary routinely collected healthcare data from England, Scotland and Wales.
Swann OV; Lone NI; Harrison EM; Tomlinson LA; Walker AJ; Seaborne MJ; Pollock L; Farrell J; Hall PS; Seth S; Williams TC; Preston J; Ainsworth JS; Semple FF; Baillie JK; Katikireddi SV; Akbari A; Lyons R; Simpson CR; Semple MG; Goldacre B; Brophy S; Sheikh A; Docherty AB
BMJ Open; 2022 Nov; 12(11):e063271. PubMed ID: 36356998
[TBL] [Abstract][Full Text] [Related]
22. Mental health in the COVID-19 pandemic: A longitudinal analysis of the CLoCk cohort study.
Panagi L; White SR; Pinto Pereira SM; Nugawela MD; Heyman I; Sharma K; Stephenson T; Chalder T; Rojas NK; Dalrymple E; McOwat K; Simmons R; Swann O; ; Ford T; Shafran R
PLoS Med; 2024 Jan; 21(1):e1004315. PubMed ID: 38266043
[TBL] [Abstract][Full Text] [Related]
23. Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study.
Søraas A; Kalleberg KT; Dahl JA; Søraas CL; Myklebust TÅ; Axelsen E; Lind A; Bævre-Jensen R; Jørgensen SB; Istre MS; Kjetland EF; Ursin G
PLoS One; 2021; 16(8):e0256142. PubMed ID: 34437579
[TBL] [Abstract][Full Text] [Related]
24. Long COVID outcomes following omicron wave in non-hospital population.
Ruiyin W; Qi J; Tingting W; Yuqin Y; Yan J; Kun P
Front Public Health; 2024; 12():1377866. PubMed ID: 38560433
[TBL] [Abstract][Full Text] [Related]
25. Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom.
Vihta KD; Pouwels KB; Peto TEA; Pritchard E; Eyre DW; House T; Gethings O; Studley R; Rourke E; Cook D; Diamond I; Crook D; Matthews PC; Stoesser N; Walker AS;
Clin Infect Dis; 2022 Aug; 75(1):e329-e337. PubMed ID: 34748629
[TBL] [Abstract][Full Text] [Related]
26. Three-Month Symptom Profiles Among Symptomatic Adults With Positive and Negative Severe Acute Respiratory Syndrome Coronavirus 2 Tests: A Prospective Cohort Study From the INSPIRE Group.
Spatz ES; Gottlieb M; Wisk LE; Anderson J; Chang AM; Gentile NL; Hill MJ; Huebinger RM; Idris AH; Kinsman J; Koo K; Li SX; McDonald S; Plumb ID; Rodriguez RM; Saydah S; Slovis B; Stephens KA; Unger ER; Wang RC; Yu H; Hota B; Elmore JG; Weinstein RA; Venkatesh A
Clin Infect Dis; 2023 May; 76(9):1559-1566. PubMed ID: 36573005
[TBL] [Abstract][Full Text] [Related]
27. Follow-up of SARS-CoV-2 positive subgroup from the Asymptomatic novel CORonavirus iNFection study.
Meyers KJ; Dillman B; Williams C; Jiang J; Clifford N; Miller JL; Jones ME; Goetz IA; Botros FT; Knorr J; Manner DH; Woodward B
J Med Virol; 2021 May; 93(5):2925-2931. PubMed ID: 33463731
[TBL] [Abstract][Full Text] [Related]
28. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
medRxiv; 2020 Oct; ():. PubMed ID: 33106813
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
[TBL] [Abstract][Full Text] [Related]
30. Acute and Persistent Symptoms in Children With Polymerase Chain Reaction (PCR)-Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Compared With Test-Negative Children in England: Active, Prospective, National Surveillance.
Zavala M; Ireland G; Amin-Chowdhury Z; Ramsay ME; Ladhani SN
Clin Infect Dis; 2022 Aug; 75(1):e191-e200. PubMed ID: 34849658
[TBL] [Abstract][Full Text] [Related]
31. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of Select New Symptoms and Conditions Among Persons Aged Younger Than 20 Years and 20 Years or Older at 31 to 150 Days After Testing Positive or Negative for SARS-CoV-2.
Hernandez-Romieu AC; Carton TW; Saydah S; Azziz-Baumgartner E; Boehmer TK; Garret NY; Bailey LC; Cowell LG; Draper C; Mayer KH; Nagavedu K; Puro JE; Rasmussen SA; Trick WE; Wanga V; Chevinsky JR; Jackson BR; Goodman AB; Cope JR; Gundlapalli AV; Block JP
JAMA Netw Open; 2022 Feb; 5(2):e2147053. PubMed ID: 35119459
[TBL] [Abstract][Full Text] [Related]
33. Persistent symptoms are associated with long term effects of COVID-19 among children and young people: Results from a systematic review and meta-analysis of controlled studies.
Behnood S; Newlands F; O'Mahoney L; Haghighat Ghahfarokhi M; Muhid MZ; Dudley J; Stephenson T; Ladhani SN; Bennett S; Viner RM; Bhopal R; Kolasinska P; Shafran R; Swann OV; Takeda A
PLoS One; 2023; 18(12):e0293600. PubMed ID: 38153928
[TBL] [Abstract][Full Text] [Related]
34. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people.
Elliott J; Whitaker M; Bodinier B; Eales O; Riley S; Ward H; Cooke G; Darzi A; Chadeau-Hyam M; Elliott P
PLoS Med; 2021 Sep; 18(9):e1003777. PubMed ID: 34582457
[TBL] [Abstract][Full Text] [Related]
35. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study.
Borch L; Holm M; Knudsen M; Ellermann-Eriksen S; Hagstroem S
Eur J Pediatr; 2022 Apr; 181(4):1597-1607. PubMed ID: 35000003
[TBL] [Abstract][Full Text] [Related]
36. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews.
Karaarslan F; Demircioğlu Güneri F; Kardeş S
Rheumatol Int; 2021 Jul; 41(7):1263-1271. PubMed ID: 33978818
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal Household Assessment of Respiratory Illness in Children and Parents During the COVID-19 Pandemic.
de Hoog MLA; Sluiter-Post JGC; Westerhof I; Fourie E; Heuvelman VD; Boom TT; Euser SM; Badoux P; Reusken C; Bont LJ; Sanders EAM; Jaddoe VWV; Herpers BL; Eggink D; Wildenbeest JG; Duijts L; van Houten MA; Bruijning-Verhagen PCJL
JAMA Netw Open; 2022 Oct; 5(10):e2237522. PubMed ID: 36264578
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting.
Nehme M; Braillard O; Chappuis F; Courvoisier DS; Guessous I;
Ann Intern Med; 2021 Sep; 174(9):1252-1260. PubMed ID: 34224254
[TBL] [Abstract][Full Text] [Related]
39. Post-COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection.
Funk AL; Kuppermann N; Florin TA; Tancredi DJ; Xie J; Kim K; Finkelstein Y; Neuman MI; Salvadori MI; Yock-Corrales A; Breslin KA; Ambroggio L; Chaudhari PP; Bergmann KR; Gardiner MA; Nebhrajani JR; Campos C; Ahmad FA; Sartori LF; Navanandan N; Kannikeswaran N; Caperell K; Morris CR; Mintegi S; Gangoiti I; Sabhaney VJ; Plint AC; Klassen TP; Avva UR; Shah NP; Dixon AC; Lunoe MM; Becker SM; Rogers AJ; Pavlicich V; Dalziel SR; Payne DC; Malley R; Borland ML; Morrison AK; Bhatt M; Rino PB; Beneyto Ferre I; Eckerle M; Kam AJ; Chong SL; Palumbo L; Kwok MY; Cherry JC; Poonai N; Waseem M; Simon NJ; Freedman SB;
JAMA Netw Open; 2022 Jul; 5(7):e2223253. PubMed ID: 35867061
[TBL] [Abstract][Full Text] [Related]
40. Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study.
Haddad A; Janda A; Renk H; Stich M; Frieh P; Kaier K; Lohrmann F; Nieters A; Willems A; Huzly D; Dulovic A; Schneiderhan-Marra N; Jacobsen EM; Fabricius D; Zernickel M; Stamminger T; Bode SFN; Himpel T; Remppis J; Engel C; Peter A; Ganzenmueller T; Hoffmann GF; Haase B; Kräusslich HG; Müller B; Franz AR; Debatin KM; Tönshoff B; Henneke P; Elling R
EBioMedicine; 2022 Oct; 84():104245. PubMed ID: 36155957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
